Post-stroke upper limb spasticity
Conditions
Interventions
Experimental group (TEAS group):Transcutaneous electrical acupoint stimulation of the affected upper limb acupoints
Control group (fake TEAS group):Pseudo-transcutaneous electrical acupoint stimulation of the affected upper limb acupoints
Sponsors
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
30 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1) Meets the diagnostic criteria for stroke; 2) Onset time between 1 month to 12 months; 3) Exhibits symptoms such as upper limb paralysis and increased muscle tone with assessment standards referring to Brunnstrom stages II to IV (spastic phase) for upper limb spasticity 20 = FMA-UE = 50; 4) Age between 30 and 75 years; 5) Vital signs stable clear consciousness no significant language communication barriers and cognitive function generally normal; 6) Patient or family member signs informed consent.
Exclusion criteria
Exclusion criteria: 1) Patients with upper limb spasm prior to this stroke episode; 2) Patients with upper limb spasm caused by other neurological disorders; 3) Patients with other diseases affecting limb motor function such as rheumatoid arthritis fractures trauma and joint diseases; 4) Patients at high risk of recurrent death; 5) Patients with comorbid mental disorders or severe dysfunction of important organs such as the heart liver and kidneys as well as severe primary diseases of the hematological and endocrine systems; 6) Patients with contraindications for percutaneous acupoint electrical stimulation (such as electronic implants) or those with anxiety that the doctor believes may lead to loss of follow-up; 7) Patients with infections ulcers or scars at the selected acupoint sites; 8) Pregnant or breastfeeding women; 9) Patients who are currently undergoing or have undergone electrical or magnetic stimulation therapy muscle relaxants or injections of botulinum toxin A within the past 30 days which may affect the assessment of this study's efficacy; 10) Patients with contraindications for sEMG such as the presence of implanted medical devices severe skin injuries or severe allergies to electrode pads making it impossible to place electrodes or causing discomfort during the examination; patients who are extremely agitated and cannot be sedated or cooperate with the examination at that time.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Upper limb Fugl-Meyer assessment; | — |
Secondary
| Measure | Time frame |
|---|---|
| Degree of muscle spasm;Motor function;Change in flexion and extension angles;Myoelectric activity of muscle;Degree of pain;Ability of daily living; | — |
Countries
China
Contacts
Public ContactJian LIU
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Outcome results
None listed